Alkermes, Janssen Enter Arbitration Over NanoCrystal Tech
Biopharmaceutical company Alkermes PLC said it has entered binding arbitration with Johnson & Johnson subsidiary Janssen Pharmaceutica NV over two licensing agreements for small particle pharmaceutical compound technology Janssen uses in...To view the full article, register now.
Already a subscriber? Click here to view full article